Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic disparities in cancer treatment and academic research, during ninth annual Cancer Immunotherapy Month...
25-May-2021 7:00 PM EDT Add to Favorites
Cancer Research Institute and RevImmune Announce Dosing of First Patient in New Phase 2 Study Assessing Therapeutic Benefit of Interleukin-7 in Patients with Cancer and COVID-19
New immunotherapy approach to treating cancer patients with COVID-19 aims to reduce risk of severe COVID-19 symptoms by reinvigorating patients' cellular immune responses
30-Mar-2021 7:00 AM EDT Add to Favorites
Cancer Research Institute CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey Receives Inaugural Tara Withington Public Service Award from the Society for Immunotherapy of Cancer
Award honors individuals and organizations that foster and enhance the field of cancer immunotherapy through increasing public understanding, awareness, research efforts, and/or funding
11-Nov-2020 4:00 PM EST Add to Favorites
Combination Drug Strategies Gain Ground in Global Immuno-Oncology Pipeline of PD-1 and PD-L1 Clinical Trials, New Report from Cancer Research Institute Reveals
Analysis update by the nonprofit Cancer Research Institute reveals dramatic growth in PD-1/PD-L1 monoclonal antibody combination cancer treatment strategies in global clinical trial pipeline
11-Nov-2020 11:35 AM EST Add to Favorites
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.
18-Sep-2020 8:30 AM EDT Add to Favorites
Cancer Research Institute Goes Virtual for Its Immunotherapy Patient Summit Series, Connecting Patients and Caregivers with Leading Experts in Cancer Immunotherapy
Free virtual event October 2-3 connecting cancer patients and caregivers with leading immunotherapy experts and patient advocates treated with immunotherapy
17-Sep-2020 4:45 PM EDT Add to Favorites
Cancer Research Institute Announces Recipients of 2020 Philanthropy and Science Awards to Be Presented at Virtual Gala, Innovators in Science and Philanthropy
Honorees recognized for supporting and making significant scientific advancements in cancer immunotherapy research to help create better treatment options for cancer patients
10-Sep-2020 7:00 AM EDT Add to Favorites
Cancer Research Institute Awards $30.2 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy
The Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, awarded more than $30.2 million in research grants and fellowships in the 2020 fiscal year...
5-Aug-2020 2:00 PM EDT Add to Favorites
See All News
The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT
Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT